Clinical Trial Update: Evaluating Kineret® (Anakinra) in Rheumatoid Arthritis (RA) Subjects Using aSelf-Reported Questionnaire [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Kineret (Anakinra) in rheumatoid arthritis patients using a self-reported questionnaire. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• KINERET (ANAKINRA)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED